Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. news
  3. health to deploy system
Show results for

Refine by
Date

  • Older

Health To Deploy System Articles & Analysis

296 news found

2024: A year of growth and learning at Datum Electronics

2024: A year of growth and learning at Datum Electronics

As 2024 draws to a close, it’s the perfect time to reflect on the incredible strides we’ve made this year – not only as a company but as a team committed to continuous improvement and growth. At Datum Electronics, we firmly believe that investing in our people is key to driving success, and this year’s training and development efforts have been a testament to that ...

ByDatum Electronics Ltd


SOPHiA Genetics Announces It Joins the European Liquid Biopsy Society at ECP 2024

SOPHiA Genetics Announces It Joins the European Liquid Biopsy Society at ECP 2024

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that the company is joining the European Liquid Biopsy Society (ELBS), a prestigious network consisting of partners from academia and industry with the common goal of making liquid biopsy tests part of the routine standard of care. SOPHiA GENETICS offers a ...

BySOPHiA Genetics


Synaptive Medical to Test New Software for Brain Surgery Planning at Unity Health Toronto

Synaptive Medical to Test New Software for Brain Surgery Planning at Unity Health Toronto

Planning brain surgery is a delicate process that requires precision to avoid damaging surrounding brain tissue and to prevent post-surgery complications. Synaptive Medical, a leader in medical technology, is set to enhance this process by evaluating its new software called Modus Plan, at Unity Health Toronto’s St. Michael’s Hospital, with support from OBIO’s Life Sciences ...

BySynaptive Medical


Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC

Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC

Tempus, a leader in artificial intelligence and precision medicine, today announces an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm physicians with technology that supports the delivery of guideline-directed biomarker testing for patients with non-small cell lung cancer (NSCLC). The magnitude and frequency of updates to oncology guidelines each year make it ...

ByTempus


Caresyntax Announces Highlights of 2023

Caresyntax Announces Highlights of 2023

Caresyntax, the leading vendor of enterprise-scale data-driven surgical intelligence solutions to make surgery safer and smarter, today announced its highlights and achievements of 2023, as the company has continued its strong growth journey. Dennis Kogan, co-founder, and CEO: “Caresyntax celebrated its 10-year anniversary in 2023 and accelerated our journey of innovation and expansion ...

ByCaresyntax


Caresyntax Announces Launch of Novel Real World Evidence (RWE) Program and Software Portfolio of Digital Catalysts for Commercial Acceleration of Medtech Partners

Caresyntax Announces Launch of Novel Real World Evidence (RWE) Program and Software Portfolio of Digital Catalysts for Commercial Acceleration of Medtech Partners

Ramshaw’s to our centralized surgical intelligence platform, and with our constantly evolving suite of tech catalysts, we can help usher in a new era of surgical data science with measurable value for all players in the space: health systems, clinicians, payors, and now MedTechs,” Dennis Kogan, CEO of Caresyntax. ...

ByCaresyntax


Caresyntax Future of Surgery Dinners: Where Excellence Meets Innovation

Caresyntax Future of Surgery Dinners: Where Excellence Meets Innovation

In the world of healthcare and innovation, where the qualitative and financial pressures are high and the challenges are complex, there exists a unique and exclusive gathering that is working to revolutionize the future of surgery. They are the Caresyntax Future of Surgery Dinners, and they are a unique format for bringing together leaders of health systems, med tech, surgery, insurance, and ...

ByCaresyntax


FDA Establishes New Medical Device Category: FDA Authorization Now Required to Market UV Robots to Healthcare Facilities

FDA Establishes New Medical Device Category: FDA Authorization Now Required to Market UV Robots to Healthcare Facilities

The U.S. Food and Drug Administration (“FDA”) has announced a new medical device product classification “whole room microbial reduction device” which establishes FDA regulation of UV robots intended to reduce the number of pathogens in unoccupied patient rooms, operating rooms and other areas in healthcare facilities where non-critical medical devices are present. ...

ByXenex Disinfection Services Inc.


TOMI Secures Vizient Contract as an Approved Supplier of SteraMist Systems for Nationwide Healthcare Networks

TOMI Secures Vizient Contract as an Approved Supplier of SteraMist Systems for Nationwide Healthcare Networks

TOMI Environmental Solutions, Inc.® ("TOMI") (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced that the Company has entered into a contract with Vizient, Inc. increasing TO Mi's presence in the U.S. healthcare system. Vizient is the largest group purchasing organization (GPO) in the healthcare industry supplying around $100 billion in ...

BySteraMist Disinfection


Bayer initiates phase III study to investigate aflibercept 8 mg in retinal vein occlusion

Bayer initiates phase III study to investigate aflibercept 8 mg in retinal vein occlusion

Global phase III QUASAR study will assess the efficacy and safety of aflibercept 8 mg in macular edema secondary to retinal vein occlusion (RVO) Study comes after positive data from the phase III PULSAR trial in neovascular (wet) age-related macular degeneration (nAMD) and phase II/III PHOTON trial in diabetic macular edema (DME) QUASAR is expected to enroll around 800 patients in 27 ...

ByBayer AG


miR Scientific and Leonie Hill Capital Announce Collaboration to Introduce Breakthrough Urine Liquid Biopsy Prostate Cancer Test in Singapore

miR Scientific and Leonie Hill Capital Announce Collaboration to Introduce Breakthrough Urine Liquid Biopsy Prostate Cancer Test in Singapore

High demand seen for effective disease management platform for second most common cancer in Singaporean men NEW YORK and SINGAPORE, March 28, 2022 /PRNewswire/ -- miR Scientific, a New York-based healthcare company dedicated to transforming global cancer management, and Leonie Hill Capital, a Singapore-based organization focused on large-scale, sophisticated healthcare access and distribution, ...

BymiR Scientific, LLC


Segmed Ethics Committee Recap

Segmed Ethics Committee Recap

Anonymized medical data sharing is necessary for the advancement of medicine, but it requires a tremendous amount of trust from all stakeholders. Patients need to trust that their healthcare providers are utilizing their data to advance innovations that will help them in the future. Healthcare providers such as health systems and hospitals must trust external stakeholders to use that data for ...

BySegmed, Inc.


Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22

Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22

iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading cardiovascular diagnostics and digital healthcare solutions company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the results of four clinical studies presented at the American Heart Association’s (AHA) 2022 Scientific Sessions in Chicago, IL. The studies demonstrate health economic and ...

ByZio by iRhythm Technologies, Inc.


iRhythm announces results of four studies to be unveiled at American Heart Association Scientific Sessions

iRhythm announces results of four studies to be unveiled at American Heart Association Scientific Sessions

iRhythm Technologies will have the results of four studies presented by leading clinical investigators at the American Heart Association’s 2022 Scientific Sessions on Nov. 5-7 in Chicago, Illinois. The studies listed below focus on iRhythm’s core suite of Zio XT and AT patch-based extended and mobile cardiac monitoring products and services. Saturday, Nov. 5 3:00 – 4:00 p.m. ...

ByZio by iRhythm Technologies, Inc.


electroCore, Inc. Announces Distribution Agreement with Joerns Healthcare, LLC

electroCore, Inc. Announces Distribution Agreement with Joerns Healthcare, LLC

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that gammaCore Sapphire™, the first and only FDA-cleared, non-invasive device to treat and prevent multiple types of headache pain via the vagus nerve, will be distributed and billed exclusively by Joerns Healthcare, LLC (Joerns) within selected managed care health systems. ...

ByelectroCore, Inc.


A2EI, Odyssey and GBE collaborate to remotely monitor healthcare infrastructure electrification in Benin

A2EI, Odyssey and GBE collaborate to remotely monitor healthcare infrastructure electrification in Benin

According to surveys carried out by the GBE project in Benin between 2020-2021, over 69% of solar systems installed at health centres in Benin in the past five years prior were no longer working. With much focus put on installing solar systems at health centres, very little attention is placed on what happens after commissioning. In most cases, due to lack of maintenance and proper care, solar ...

ByOdyssey Energy Solutions


Why Innovation in Blood Testing Matters

Why Innovation in Blood Testing Matters

Why should payers care about clinical laboratory testing? Clinical laboratory testing plays an essential role in the delivery of health care. From early detection and diagnosis of disease to individualized treatment plans based on a person’s unique biology, medical care depends on accurate and timely health data. Seventy percent of medical decisions depend on lab test results, so making ...

ByBabson Diagnostics


Diagnostics-4-Future Conference

Diagnostics-4-Future Conference

Meet us from October 12 – 13, 2022 at the Diagnostics-4-Future conference in Konstanz and learn more about our know-how in the fields of contract manufacturing, contract development, lifecycle management and many more. Meet LRE Medical at booth #16 or if you would like to set an appointment, please reach out to Claudia Strehle at strehle@lre.de. Diagnostics-4-Future is an ...

ByLRE Medical


Immunological analysis of prevention trial with Diamyd published in peer-reviewed scientific journal

Immunological analysis of prevention trial with Diamyd published in peer-reviewed scientific journal

Results of an analysis of a previous prevention trial with Diamyd® (GAD-alum) treatment, which indicate a positive and sustained immunomodulating effect after treatment with Diamyd® in healthy children at risk for type 1 diabetes, have been published in the scientific journal Journal of Immunology Research. The analysis was carried out by researchers at Lund University and provides ...

ByDiamyd Medical AB


Iterative Scopes Receives FDA Clearance for AI-Assisted Polyp Detection Device SKOUT

Iterative Scopes Receives FDA Clearance for AI-Assisted Polyp Detection Device SKOUT

Iterative Scopes, a pioneer in precision medicine technologies for gastroenterology, and Provation, the premier software and SaaS provider of clinical productivity and workflow automation solutions, announced today that SKOUT™ has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for adults undergoing colorectal cancer screening or surveillance. SKOUT, a real-time ...

ByIterative Health, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT